View More View Less
  • 1 Semmelweis Egyetem, Általános Orvostudományi Kar Bőr-, Nemikórtani és Bőronkológiai Klinika Budapest Mária u. 41. 1085
Open access

A szexuálisan terjedő betegségek gyakori közös előfordulását magyarázza a közös terjedési mód, ugyanakkor a szexuális úton terjedő kórokozók fokozzák egymás infektivitását. A szexuális úton terjedő koinfekciók egyértelműen kedvezőtlen hatásúak a szervezetre: rosszabb prognózist, eltérő, súlyosabb klinikai képet okoznak. A szerzők közleményükben a HIV és a szexuális úton terjedő koinfekciókat részletezik (HIV és B-vírus hepatitis; HIV és syphilis; HIV és gonorrhoea; HIV és Chlamydia trachomatis). Ezek a szexuális úton terjedő fertőzések gyakrabban fordulnak elő HIV fertőzötteken, amit a közös terjedési mód és immunkárosodás mellett egyéb tényezők magyaráznak (barrierfunkciók sérülése, genitális nyálkahártya gyulladása következtében kialakult emelkedett citokinszint). A koinfekciók során a klinikai kép, a szövődmények, a prognózis és a terápiás válasz változnak, továbbá diagnosztikus nehézségek léphetnek fel. A szexuálisan terjedő betegségek elleni eredményes fellépésben fontos szerepe van az együttes fertőzések felismerésének, valamint komplex diagnosztikus, kezelési és megelőzési módszerek (felvilágosítás, nevelés) alkalmazásának Orv. Hetil., 2015, 156(1), 4–9.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Fleming, D. T., Wasserheit, J. N: From epidemiological synergy to public health policy and practice. The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect., 1999, 75(1), 3–17.

  • Cohen, M. S.: Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet, 1998, 351(Suppl. 3), 5–7.

  • Rogers, A. S., Lindsey, J. C., Futterman, D. C., et al.: Serologic examination of hepatitis B infection and immunization in HIV-positive youth and associated risks. The Pediatric AIDS Clinical Trials Group Protocol 220 Team. AIDS Patient Care STDs, 2000, 14(12), 651–657.

  • Kiire, C. F.: The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut, 1996, 38(Suppl. 2 ), S5–S12.

  • Hoffmann, C. J., Charalambous, S., Martin, D. J., et al.: Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin. Infect. Dis., 2008, 47(11), 1479–1485.

  • Matthews, P., Geretti, A. M., Goulder, P. J., et al.: Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. J. Clin. Virol., 2014, 61(1), 20–33.

  • Burnett, R. J., François, G., Kew, M. C., et al.: Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver Int., 2005, 25(2), 201–213.

  • Hoffmann, C. J., Dayal, D., Cheyip, M., et al.: Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South-Africa. Int. J. STD AIDS, 2012, 23(10), e10–e13.

  • Bodsworth, N. J., Cooper, D. A., Donovan, B.: The influence of human immunodeficiency virus type I infection on the development of the hepatitis B virus carrier state. J. Infect. Dis., 1991, 163(5), 1138–1140.

  • Ioannou, G. N., Bryson, C. L., Weiss, N. S., et al.: The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology, 2013, 57(1), 249–257.

  • Nikolopoulos, G. K., Paraskevis, D., Hatzitheodorou, E., et al.: Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin. Infect. Dis., 2009, 48(12), 1763–1771.

  • Wandeler, G., Gsponer, T., Bihl, F., et al.: Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study. J. Infect. Dis., 2013, 208(9), 1454–1458.

  • Stabinski, L., Reynolds, S. J., Ocama, P., et al.: High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda. Antivir. Ther., 2011, 16(3), 405–411.

  • Dervisevic, S., Pillay, D.: Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infection. J. HIV Ther., 2003, 8(4), 89–95.

  • Petty, L. A., Steinbeck, J. L., Pursell, K., et al.: Human immunodeficiency virus and coinfection with hepatitis B and C. Infect. Dis. Clin. North Am., 2014, 28(3), 477–499.

  • Di Bisceglie, A. M., Maskew, M., Schulze, D., et al.: HIV-HVB coinfection among South African patient receiving antiretroviral therapy. Antivir. Ther., 2010, 15(3 Pt B), 499–503.

  • Soriano, V., Puoti, M., Peters, M., et al.: Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS, 2008, 22(12), 1399–1410.

  • Rockstroh, J. K., Bhagani, S., Benhamou, Y., et al.: European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med., 2008, 9(2), 82–88.

  • Antonucci, G., Mazzotta, F., Angeletti, C., et al.: Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy. BMC Res. Notes, 2013, 6, 153.

  • Brook, G., Main, J., Nelson, M., et al.: British HIV association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus. HIV Med., 2010, 11(1), 1–30.

  • Moss, W. J., Clements, C. J., Halsey, N. A.: Immunization of children at risk of infection with human immunodeficiency virus. Bull. World Health Organ., 2003, 81(1), 61–70.

  • Whitaker, J. A., Rouphael, N. G., Edupuganti, S., et al.: Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1. Lancet Infect. Dis., 2012, 12(12), 966–976.

  • Sulkowski, M. S., Thomas, D. L.: Hepatitis C in the HIV-infected person. Ann. Intern. Med., 2003, 138(3), 197–207.

  • Thomas, D. L., Astemborski, J., Rai, M. R., et al.: The natural history of hepatitis C virus infection: host, viral and environmental factors. JAMA, 2000, 284(4), 450–456.

  • Ragni, M. V., Belle, S. H.: Impact of human immunodeficiency virus infection on progression of end-stage liver disease in individual with haemophilia and hepatitis C virus infection. J. Infect. Dis., 2001, 183(7), 1112–1115.

  • Clausen, L. N., Lundbo, L. F., Benfield, T.: Hepatitis C virus infection in the human immunodeficiency virus infected patient. World J. Gastroenterol., 2014, 20(34), 12132–12143.

  • Shah, N., Pierce, T., Kowdley, K. V.: Review of direct-acting antiviral agents for the treatment of chronic hepatitis C. Expert Opin. Investig. Drugs, 2013, 22(9), 1107–1121.

  • Spaulding, A. B., Lifson, A. R., Iverson, E. R., et al., Infectious Disease Clinical Research Program HIV Working Group: Gonorrhoea or chlamydia in a U.S. military HIV-positive cohort. Sex. Transm. Infect., 2012, 88(4), 266–271.

  • Page, K. R., Moore, R. D., Wilgus, B., et al.: Neisseria gonorrhoeae and Chlamydia trachomatis among human immunodeficiency virus-infected women. Sex. Trans. Dis., 2008, 35(10), 859–861.

  • Cohen, M. S., Hoffman, I. F., Royce, R. A., et al.: Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet, 1997, 349(9069), 1868–1873.

  • Mitchell, C., Hitti, J., Paul, K., et al.: Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota. AIDS Res. Hum. Retroviruses, 2011, 27(1), 35–39.

  • Bebell, L. M., Passmore, J. A., Williamson, C., et al.: Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. J. Infect. Dis., 2008, 198(5), 710–714.

  • Körber, A., Dissemond, J., Lehnen, M., et al.: Syphilis bei HIV-koinfektion. J. Dtsch. Dermatol. Ges., 2004, 2(10), 833–840.

  • Weintrob, A. C., Crum-Cianflone, N., Michael, N. L.: Syphilis and human immunodeficiency virus coinfection: more than the sum of its parts. Infect. Dis. Clin. Practice, 2006, 14(4), 197–203.

  • Kofoed, K., Gerstoft, J., Mathiesen, L., et al.: Syphilis and human immundeficiency virus HIV-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response. Sex. Transm. Dis., 2006, 33(3), 143–148.

  • Buchacz, K., Patel, P., Taylor, M., et al.: Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS, 2004, 18(15), 2075–2079.

  • Sadiq, S. T., McSorley, J., Copas, A. J., et al.: The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen. Sex. Transm. Infect., 2005, 81(15), 380–385.

  • Sammet, S. C., Niedermeier, A., Bogner, J., et al.: Unusual faces of syphilis. Hautarzt, 2012, 63(5), 415–422.

  • Tyler, K. L., Sandberg, E., Baum, K. F.: Medical medullary syndrome and meningovascular syphilis: a case report in an HIV-infected man and a review of the literature. Neurology, 1994, 44(12), 2231–2235.

  • Pónyai, K., Ostorházi, E., Mihalik, N., et al.: Syphilis and HIV coinfection – Hungarian Sexually Transmitted Infection Centre experience between 2005 and 2013. Acta Microbiol. Immunol. Hung., 2013, 60(3), 247–259.

  • Tóth, V., Hornyák, Cs., Kovács, T., et al.: Meningovascular neurosyphilis as the cause of ischemic cerebrovascular disease in a young man. [Meningovascularis neurosyphilis miatti fiatalkori ischaemiás cerebrovascularis betegség.] Orv. Hetil., 2011, 152(19), 763–767. [Hungarian]

  • Mayer, K. H.: Sexually transmitted diseases in men who have sex with men. Clin. Infect. Dis., 2011, 53(Suppl.), S79–S83.

  • Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm. Rep., 2008, 57(RR-9), 1-83.

  • Professional Body of Dermatology and Venereal Diseases: Methodological guideline for the diagnosis and treatment of sexually transmitted infections – 2002. [Bőr- és Nemibetegségek Szakmai Kollégiuma: Módszertani ajánlás a szexuális úton terjedő infekciók kivizsgálására és kezelésére – 2002.] Egészségügyi Közlöny, 2002, 52(11), 1509–1518. [Hungarian]

  • Fenton, K., Breban, R., Vardavas, R., et al.: Infectious syphilis in high income settings in the 21st century. Lancet Infect. Dis., 2008, 8(4), 244–253.

  • Jinno, S., Ankern B., Kaur, P., et al.: Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging era of universal antiretroviral therapy use. BMC Infect. Dis., 2013, 13, 605.

  • Muldoon, E. G., Mooka, B., Reidy, D., et al.: Long-term neurological follow-up of HIV-positive patients diagnosed with syphilis. Int. J. STD AIDS, 2012, 23(9), 676–678.

  • Luger, A. F., Schmidt, B. L., Kaulich, M.: Significance of laboratory findings for the diagnosis of neurosyphilis. Int. J. STD AIDS, 2000, 11(4), 224–234.

  • Fleming, D. T., Wasserheit, J. N.: From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect., 1999, 75(1), 3–17.

  • Paavonen, J.: Immunopathogenesis of pelvic inflammatory disease and infertility – what do we know, what shall we do? J. Br. Fert. Soc., 1996, 1(1), 42–45.

 

The author instructions are available in PDF.
Instructions for Authors in Hungarian HERE.

 

Mendeley citation style is available HERE.

Senior editors

Editor(s)-in-Chief: Papp Zoltán

Read the professional career of Papp Zoltán HERE.

 

Editorial Board

Click for the Editorial Board

Akadémiai Kiadó
Address: Prielle Kornélia u. 21-35. H-1117 Budapest, Hungary
Phone: (+36 1) 464 8235 ---- Fax: (+36 1) 464 8221
Email: orvosihetilap@akkrt.hu

2019  
Total Cites
WoS
1 085
Impact Factor 0,497
Impact Factor
without
Journal Self Cites
0,212
5 Year
Impact Factor
0,396
Immediacy
Index
0,126
Citable
Items
247
Total
Articles
176
Total
Reviews
71
Cited
Half-Life
6,1
Citing
Half-Life
7,3
Eigenfactor
Score
0,00071
Article Influence
Score
0,045
% Articles
in
Citable Items
71,26
Normalized
Eigenfactor
0,08759
Average
IF
Percentile
10,606
Scimago
H-index
20
Scimago
Journal Rank
0,176
Scopus
Scite Score
864/1178=0,4
Scopus
Scite Score Rank
General Medicine 267/529 (Q3)
Scopus
SNIP
0,254
Acceptance
Rate
73%

 

Language: Hungarian

Founded in 1857
Publication: Weekly, one volume of 52 issues annually